Biotech
SEATTLE, WA: SEATTLE, WA -- (Marketwired) -- 06/30/17 -- Atossa Genetics Inc. (NASDAQ: ATOS), a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other ...
RENO, NV: RENO, NV -- (Marketwired) -- 06/30/17 -- (OTC PINK: LLBO)The Company recently transferred breast cancer detection technology to Cyrcadia, Inc. in exchange for 4,670,000 shares of Cyrcadia, Inc. commo ...
CAMBRIDGE, MASSACHUSETTS: CAMBRIDGE, MASSACHUSETTS -- (Marketwired) -- 06/28/17 -- VBI Vaccines Inc. (NASDAQ: VBIV)(TSX: VBV) ("VBI") today announced the voting results from its annual general and special meeting ( ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 06/28/17 -- Trillium Therapeutics Inc. (TSX: TRIL)(NASDAQ: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of c ...
CITY OF INDUSTRY, CA: Company to narrow its business focus to pain and hypertension; Company plans to sell or divest the oligonucleotide therapeutic assets ...
CAMBRIDGE, MASSACHUSETTS: CAMBRIDGE, MASSACHUSETTS -- (Marketwired) -- 06/26/17 -- VBI Vaccines, Inc. (NASDAQ: VBIV)(TSX: VBV) ("VBI"), a commercial-stage biopharmaceutical company developing next-generation infect ...
SEATTLE, WA: SEATTLE, WA -- (Marketwired) -- 06/26/17 -- Atossa Genetics Inc. (NASDAQ: ATOS), a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods to treat breast cancer and ...
CAMBRIDGE, MASSACHUSETTS: CAMBRIDGE, MASSACHUSETTS -- (Marketwired) -- 06/19/17 -- VBI Vaccines Inc. (NASDAQ: VBIV)(TSX: VBV) ("VBI"), a commercial-stage biopharmaceutical company developing next-generation infectio ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 06/19/17 -- IBEX Technologies Inc. ("IBEX" or the "Company") (TSX VENTURE: IBT) today reported its financial results for the nine months ende ...
SAN ANTONIO, TEXAS: SAN ANTONIO, TEXAS -- (Marketwired) -- 06/15/17 -- Nerium Biotechnology, Inc. ("Nerium" or the "Company") today announces that it is mailing a letter to shareholders in advance o ...
TUSTIN, CA: Corporate Booth to Include Virtual Tour of Myford Late-Stage Clinical and Commercial Biomanufacturing Facility Featuring the Industry's Most Cutting-Edge, Single-Use Equipment and Flexible Soluti ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 06/07/17 -- Trillium Therapeutics Inc. (NASDAQ: TRIL)(TSX: TRIL), a clinical stage immuno-oncology company, today announced that based upon promising early eviden ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 06/07/17 -- Revive Therapeutics Ltd. ("Revive" or the "Company") (TSX VENTURE: RVV) (OTCQB: RVVTF), a company focused on the research, develo ...
EDMONTON, ALBERTA: EDMONTON, ALBERTA -- (Marketwired) -- 06/05/17 -- (TSX VENTURE: CZO) ("Ceapro" or the "Company"), a growth-stage biotechnology company focused on the development and commercializ ...
CAMBRIDGE, MASSACHUSETTS: CAMBRIDGE, MASSACHUSETTS -- (Marketwired) -- 06/05/17 -- VBI Vaccines Inc. (NASDAQ: VBIV)(TSX: VBV) ("VBI"), a commercial-stage biopharmaceutical company developing next-generation infecti ...
LONDON, ONTARIO: Sernova reports on active pharma collaboration, upcoming clinical trial and fertile BD pipeline to advance scale of diabetes and hemophilia programs ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 06/01/17 -- Trillium Therapeutics Inc. (NASDAQ: TRIL)(TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of c ...
EDMONTON, ALBERTA: - Company announces completion of PGX pilot scale facility, installation of custom-designed process equipment, and formation of expert PGX team - Agreement with University of Alberta, utilizing $332K ...
SEATTLE, WA: SEATTLE, WA -- (Marketwired) -- 06/01/17 -- Atossa Genetics, Inc. (NASDAQ: ATOS), a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods for breast cancer and othe ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 05/31/17 -- Trillium Therapeutics Inc. (NASDAQ: TRIL)(TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of c ...
